Research powered investment banking
Home
Research
Companies
Themes
Top Picks
Transactions
Events
Redeye
At a Glance
Our Culture
Research & Ratings
Investor Services
Corporate Broking
Corporate Finance
Newsroom
The Team
Careers
FAQ
Governance
Members network
Community
Posts
Investor Scoring
sign in
Member sign in
Join redeye
Home
research
Companies
Themes
Top Picks
Transactions
Events
redeye
About
At a Glance
Our Culture
Research & Ratings
Investor Services
Corporate Broking
Corporate Finance
Newsroom
The Team
Careers
FAQ
Governance
community
Posts
Investor Scoring
The latest from Redeye about Scandinavian Life Science and Technology companies
Sivers IMA
Videointervju med vd Anders Storm
Westpay
First comment Q3, delays
Paynova
Q3: Lower EBITDA than expected
Immunicum
Videointervju med vd Carlos de Sousa
Immunicum
Entering into a clinical collaboration with Merck KGaA / Pfizer
Sivers IMA
Q3 comment, solid report
Starbreeze
Våra nya estimat för OTWD
Polygiene
I väntan på det viktiga 2019
Sprint Bioscience
Slutförhandlingar i STK25-projektet
Alligator Bioscience
På väg upp i ytläge
Cherry
Still valued at a discount
Axichem
Rapportkommentar Q3
Isofol Medical
SPA dropped, initiates phase III trial
Transactions
12
Nov
IDL Biotech AB genomför nyemission för att finansiera en offensiv tillväxtstrategi
26
Nov
Eurocine vaccines inleder optionsinlösen samt införande av ny strategi
Events
20
Nov
Imint: Livesänd Q3-presentation och Q&A - 20 novem…
20
Nov
Tech Day 2018
21
Nov
Life Science Day
23
Nov
Clavister: Business update 2018
03
Dec
Investor After Work Göteborg
04
Dec
Redeye Investor After Work Stockholm
Announcements
Redeye söker framtidens aktieanalytiker
Redeye söker Sales Person till Institutional Services
Redeye sponsrar integrationsprojektet Näringslivet Möter Förorten
You need to be a Redeye member to access this content
Become a member to:
Access all our extensive research on 100+ Nordic Tech and Life Science companies
Make smarter investment decisions with the guidance of our experienced analysts
Receive exciting offers to participate in IPO’s and other transactions
Email
Password
Sign up
By clicking "Sign up" you indicate that you read and agree to our
Terms & Conditions
I already have an account and want to sign in